Momelotinib
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 228 publications
Optimized dosing of momelotinib in myelofibrosis through quantitative medicine: a clinical commentary.
Journal: Leukemia & lymphoma
Published: September 11, 2026
Computational Repurposing of Janus Kinase Inhibitors as Potential Therapeutic Candidates for Alzheimer's Disease.
Journal: Medicina (Kaunas, Lithuania)
Published: July 29, 2026
Metabolic rate-limiting enzyme-associated genes as novel biomarkers for prognosis and treatment response in lung adenocarcinoma.
Journal: Computer methods in biomechanics and biomedical engineering
Published: July 02, 2026
Reassessing the clinical value of momelotinib in myelofibrosis: An ESMO-MCBS:H-based appraisal of SIMPLIFY-1 and MOMENTUM.
Journal: Critical reviews in oncology/hematology
Published: June 29, 2026
Efficacy of pacritinib versus momelotinib in patients with thrombocytopenic myelofibrosis: a matching-adjusted indirect treatment comparison.
Journal: Expert review of hematology
Published: June 19, 2026
Janus kinase inhibitors after ruxolitinib failure in myelofibrosis: A systematic review and pooled analysis of phase 3 efficacy and integrated safety across clinical trials and real-world evidence.
Journal: British journal of haematology
Published: June 15, 2026
Roginolisib in Combination with JAK Inhibitors in Patients with Myelofibrosis Who are Unresponsive to Approved JAK Inhibitors (Study HEMA-MED) - A Trial in Progress.
Journal: OncoTargets and therapy
Published: June 10, 2026
Last Updated: 11/08/2026